(+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress via dopaminergic systems linked to phenytoin-regulated σ1 sites

European Journal of Pharmacology

Volumn 309, Issue 2, 1996, Pages 149-158

  Kamei, Hiroyuki ^a   Kameyama, Tsutomu ^a   Nabeshima, Toshitaka ^a,b  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Conditioned fear stress; Dopaminergic system; Motor suppression; Phenytoin; Receptor

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; DEXTROMETHORPHAN; N ALLYLNORMETAZOCINE; PHENYTOIN; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEAR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030575522     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00346-9     Document Type: Article

References (29)

1. 3H](+)-pentazocine-defined σ recognition sites by phenytoin, Life Sci. 53, 41.
2. Fanselow, M.S., 1980, Conditional and unconditional components of post-shock freezing, Pavlov. J. Biol. Sci. 15, 177.
3. Freeman, A.S. and B.S. Bunney, 1984, The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity, Eur. J. Pharmacol. 104, 287.
4. Gudelsky, G.A., 1995, Effects of σ receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat, Eur. J. Pharmacol. 286, 223.
5. Gundlach, A.L., B.L. Largent and S.H. Snyder, 1985, Phencyclidine and σ opiate receptors in brain: biochemical and autoradiographical differentiation, Eur. J. Pharmacol. 113, 465.
6. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine, J. Neurosci. 6, 1757.
7. Hepler, D., S.W. Tam and V.J. DeNoble, 1988, Selective PCP and sigma receptor agonists produce differential effects in rats with unilateral lesions in the substantia nigra, Soc. Neurosci. Abstr. 14, 806.
8. Iyengar, S., V.M. Dilworth, S.J. Mick, P.C. Contreras, J.B. Monahan, T.S. Rao and P.L. Wood, 1990, Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors, Brain Res. 524, 322.
9. Kamei, H., T. Kameyama and T. Nabeshima, 1994, SKF-10,047 reverses stress-induced motor suppression: interaction with dopaminergic system, Eur. J. Pharmacol, 260, 39.
10. Kamei, H., T. Kameyama and T. Nabeshima, 1995, Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress, Eur. J. Pharmacol. 273, 229.
11. 1 sites, Eur. J. Pharmacol. 299, 21.
12. Kameyama, T. and M. Nagasaka, 1982a, Effects of apomorphine and diazepam in a quickly learned conditioned suppression in rats, Pharmacol. Biochem. Behav. 17, 59.
13. Kameyama, T. and M. Nagasaka, 1982b, The effect of analgesics on quickly learned conditioned suppression in mice, Neuropharmacology 21, 1283.
14. Kameyama, T. and M. Nagasaka, 1983, Effects of apomorphine and methamphetamine on a quickly learned conditioned-suppression response in rats, Neuropharmacology 22, 813.
15. Largent, B.L., H. Wikström, A.M. Snowman and S.H. Snyder, 1988, Novel antipsychotic drugs share high affinity for σ receptors, Eur. J. Pharmacol. 155, 345.
16. Nabeshima, T., K. Yamada and T. Kameyama, 1983, Effect of opiate agonists on the conditioned suppression in motility of mice, Neurosci. Lett. 39, 301.
17. Nabeshima, T., A. Katoh, M. Hiramatsu and T. Kameyama, 1986, A role played by dopamine and opioid neuronal systems in stress-induced motor suppression (conditioned suppression of motility) in mice. Brain Res. 398, 354.
18. Nagasaka, M. and T. Kameyama, 1983, Effect of diazepam, meprobamate, chlorpromazine and apomorphine on a quickly learned conditioned suppression in mice, J. PharmacobioDyn. 6, 523.
19. Okuyama, S., Y. Imagawa, S. Ogawa, H. Araki, A. Ajima, M. Tanaka, M. Muramatsu, A. Nakazato, K. Yamaguchi, M. Yoshida and S. Otomo, 1993, NE-100, a novel σ receptor ligand-in vivo tests. Life Sci. 53, 18.
20. Patrick, S.L., J.M. Walker, J.M. Perkel, M. Lockwood and R.L. Patrick, 1993, Increases in rat striatal extracellular dopamine and vacuous chewing produced by two σ receptor ligands, Eur. J. Pharmacol. 231, 243.
21. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.P. Su, S.W. Tam and D.P. Tayllor, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci. 13, 85.
22. Quirion R., P.C. Chicheportiche, K.M. Contreras, D. Johnson, S. Lodge, W. Tam, J.H. Woods and S.R. Zukin, 1987, Classification and nomenclature of phencyclidine and sigma receptor sites, Trends Pharmacol. Sci. 10, 444.
23. Rogawski, M.A. and R.J. Porter, 1990, Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmacol. Rev. 42, 223.
24. Steinfels, G.F. and S.W. Tam, 1989, Selective σ receptor agonist and antagonist affect dopamine neuronal activity, Eur. J. Pharmacol. 163, 167.
25. Steinfels, G.F., S.W. Tam and L. Cook, 1989, Electrophysiological effects of selective σ-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons, Neuropsychopharmacology 2, 201.
26. 2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles, J. Pharmacol. Exp. Ther. 263, 1167.
27. Walker, J.M., W.D. Bowen, F.O. Walker, R.R. Matsumoto, B.D. Costa and K.C. Rice, 1990, Sigma receptors: biology and function, Pharmacol. Rev. 42, 355.
28. Wong, E.H.F., J.A. Kemp, T. Priestly, A.R. Knight, G.N. Woodruff and L.L. Iversen, 1986, The anticonvulsant MK-801 is a potent ,N-methyl-D-aspartate antagonist, Proc. Natl. Acad. Sci. USA 83, 7104.
29. Yamada, K. and T. Nabeshima, 1995, Stress-induced behavioral responses and multiple opioid systems in the brain, Behav. Brain Res. 67, 133.